Earlier menopause is associated with faster cognitive decline and greater late-life brain changes
1. Earlier age at menopause was associated with faster global and episodic memory decline, earlier Alzheimer disease diagnosis, and faster ...
Tag: cognitive decline
Older married couples demonstrate domain-specific cognitive concordance
1. In this cross-sectional study, older Korean spouses demonstrated significant concordance in verbal fluency, constructional praxis, naming, and constructional recall. ...
A cognitive rehabilitation program may improve cognitive performance in patients with long COVID
1. In a multicenter, single-blind, randomized clinical trial, participation in a cognitive rehabilitation program improved goal attainment and cognitive test ...
A multimodal approach combining cognitive assessment with biomarkers may accurately predict dementia risk
1. Plasma p-tau217 was the strongest individual biomarker for predicting progression to Alzheimer's disease dementia in patients with subjective cognitive ...
2 Minute Medicine Rewind February 12, 2024
Effect of Tai Chi vs Aerobic Exercise on Blood Pressure in Patients With Prehypertension: A Randomized Clinical Trial 1. This ...
Gantenerumab does not slow cognitive decline in early Alzheimer’s
1. In these two randomized parallel-group trials, the use of gantenerumab did not lead to slower cognitive decline over 116 ...
#VisualAbstract: Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
#VisualAbstract: Trial of Solanezumab in Preclinical Alzheimer’s Disease
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Retinal optical coherence tomography (OCT) measurements may be associated with genetic Alzheimer’s disease risk
1. In a retrospective study examining 50,000 optical coherence tomography (OCT) images from a large database, thicknesses of several different ...
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared to placebo. 2. Lecanemab also resulted ...
